Organization of the biosynthetic genes encoding deoxyactagardine B (DAB), a new lantibiotic produced by Actinoplanes liguriae NCIMB41362

Journal of Antibiotics

Volumn 63, Issue 7, 2010, Pages 351-358

  Boakes, Steven ^a   Appleyard, Antony N ^a   Cortés, Jess ^a   Dawson, Michael J ^a  

^a Novacta Biosystems Ltd   (United Kingdom)

Author keywords

Actinoplanes liguriae; antibacterials; deoxyactagardine B; lantibiotics

Indexed keywords

ACTAGARDIN; AMINO ACID; DEOXYACTAGARDINE B; LANTIBIOTIC; SULFOXIDE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

ACTINOPLANES GARBADINENSIS; ACTINOPLANES LIGURIAE; AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSPORT; GENE CLUSTER; GENE EXPRESSION; GENETIC ORGANIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STRUCTURAL GENE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIOCIN PLASMIDS; BACTERIOCINS; BASE SEQUENCE; FERMENTATION; GENES, BACTERIAL; MICROMONOSPORACEAE; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES; SEQUENCE HOMOLOGY, AMINO ACID;

ACTINOPLANES GARBADINENSIS; ACTINOPLANES LIGURIAE; LANA; LIGA;

EID: 77955106376     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2010.48     Document Type: Article

References (31)

1. Lubelski, J, Rink, R, Khusainov, R, Moll, G. N., Kuipers, O. P. Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin. Cell. Mol. Life. Sci. 65, 455-476 (2008).
2. Bierbaum, G. et al. The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7. Antonie van Leeuwenhoek 69, 119-127 (1996).
3. Parisot, J. et al. Molecular mechanism of target recognition by subtilin, a class I lanthionine antibiotic. Antimicrob. Agents Chemother. 52, 612-618 (2008).
4. Asaduzzaman, S. M., Sonomoto, K. Lantibiotics: diverse activities and unique modes of action. J. Biosci. Bioeng. 107, 475-487 (2009).
5. Majer, F, Schmid, D. G, Altena, K, Bierbaum, G., Kupke, T. The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptido- glycan biosynthesis inhibitor mersacidin. J. Bacteriol. 184, 1234-1343 (2002).
6. Widdick, D. A. et al. Cloning and engineering of the cinnamycin biosynthetic gene cluster from Streptomyces cinnamoneus cinnamoneus DSM 40005. Proc. Natl Acad. Sci. USA 100, 4316-4321 (2003).
7. Castiglione, F. et al. Determining the structure and mode of action of microbisporicin, a potent lantbiotic active against multiresistant pathogens. Chem. Biol. 15, 22-31 (2008).
8. Bierbaum, G., Sahl, H.- G. Lantibiotics: mode of action, biosynthesis and bioengi- neering. Curr. Pharma. Biotech. 10, 2-18 (2009).
9. Chatterjee, C, Paul, M, Xie, L., van der Donk, W. A. Biosynthesis and mode of action of lantibiotics. Chem. Rev. 105, 633-683 (2005).
10. Appleyard, A. N. et al. Dissecting structural and functional diversity of the lantibiotic mersacidin. Chem. Biol. 16, 1-9 (2009).
11. Piper, C, Cotter, P. D, Ross, R. P., Hill, C. Discovery of medically significant lantibiotics. Curr. DrugDisc. Techno. 6, 1-18 (2009).
12. Boakes, S, Cortes, J, Appleyard, A. N, Rudd, B. A. M., Dawson, M.J. Organization of the genes encoding the biosynthesis of actagardine and engineering of a variant generation system. Mol. Micro 72, 1126-1136 (2009).
13. Fitzgerald, N. B, English, S, Lampel, J. S., Vanden Boom, T. J. Sonication- dependent electroporation of the erythromycin-producing bacterium Saccharopolyspora erythraea. Appl. Environ. Microbiol. 64, 1580-1583 (1998).
14. Bonfield, J. K., Staden, R. The application of numerical estimates of base calling accuracy to DNA sequencing projects. Nucl. Acids Res. 23, 1406-1410 (1995).
15. Ishikawa, J., Hotta, K. FramePlot: a new implementation of the frame analysis for predicting protein-coding regions in bacterial DNA with a high G+C content. FEMS. Microbiol. Lett. 174, 251-253 (1999).
16. Parenti, F, Coronelli, C, Tamoni, G., Lancini, G. (Gruppo Lepetit Sp.A.). Gardimycin and process for producing same. US patent 4022884 May 10 (1977).
17. Vertesy, L. et al. Ala(0)-actagardine, a new lantibiotic from cultures of Actinoplanes liguriae ATCC 31048. J. Antibiot. 52, 730-741 (1999).
18. Jack, R. W, Tagg, J. R., Ray, B. Bacteriocins of Gram-positive bacteria. M crob ol. Rev. 59, 171-200 (1995).
19. Zimmerman, N., Jung, G. The three-dimensional solution structure of the lantibiotic murein-biosynthesis-inhibitor actagardine determined by NMR. Eur. J. Biochem. 246, 809-819 (1997).
20. Altena, K, Guder, A, Cramer, C., Bierbaum, G. Biosynthesis of the lantibiotic mersacidin: organization of type B lantibiotic gene cluster. Appl. Environ. Microbiol. 66, 2565-2571 (2000).
21. Navaratna, M.A.D.B, Sahl, H.- G., Tagg, J. R. Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl. Environ. Microbiol. 64, 4803-4808 (1998).
22. Arribas-Bosacoma, R. et al. The X-ray crystal structures of two constitutively active mutants of the Escherichia coli PhoB receiver domain give insights into activation. J. Mol. Biol. 366, 626-641 (2007).
23. Wisedchaisri, G. et al. Structures of Mycobacterium tuberculosis DosR and DosR-DNA complex involved in gene activation during adaptation to hypoxic latency. J. Mol. Biol. 354, 630-641 (2005).
24. Bentley, S. D. et al. Complete genome sequence of the model actinomycete Strepto- myces coelicolorA3(2). Nature 417, 141-147 (2002).
25. Holtsmark, I, Mantzilas, D, Eijsink, V. G. H., Brurberg, M. B. Purification, characterisation, and gene sequence of michiganin A, an actagardine-like lantibiotic produced by the tomato pathogen Clavibacter michiganensis subsp. michiganensis. Appl. Environ. Microbiol. 72, 5814-5821 (2006).
26. Guder, A, Schmitter, T, Wiedemann, I, Sahl, H-G., Bierbaum, G. Role of the single regulator MrsRI and the two-component system MrsR2/K2 in the regulation of mersacidin production and immunity. Appl. Environ. Microbiol. 68, 106-113 (2002).
27. Gartemann, K.- H. et al. The genome sequence of the tomato-pathogenic actinomycete Clavibacter michiganensis subsp. michiganensis NCPPB382 reveals a large island involved in pathogenicity. J. Bacteriol. 190, 2138-2149 (2008).
28. Davidson, A. L., Chen, J. ATP-binding cassette transporters in bacteria. Annu. Rev. Biochem. 73, 241-268 (2004).
29. Fisher, A. J, Thompson, T. B, Thoden, J. B, Baldwin, T. O., Rayment, I. The 1.5-A resolution crystal structure of bacterial luciferase in low salt conditions. J. Biol. Chem. 271, 21956-21968 (1996).
30. Subbian, S, Mehta, P. K, Cirillo, S. L. G., Cirillo, J. D. The Mycobacterium marinum mel2 locus displays similarity to bacterial bioluminescence systems and plays a role in defense against reactive oxygen and nitrogen species. BMC Microbiol 7: Article number 4 (2007).
31. Delihas, N. Small mobile sequences in bacteria display diverse structure/function motifs. Mol. Microbiol. 67, 475-481 (2008).